International safety notice

Urgent Field Safety Notice for ADVIA Centaur NT-proBNP and Atellica IM NT-proBNP; (N-terminal pro-brain natriuretic peptide) by Siemens Healthcare Diagnostics Inc. Tarrytown

Germany / BfArM · DEU · Jan 20, 2020

Key facts

Title Urgent Field Safety Notice for ADVIA Centaur NT-proBNP and Atellica IM NT-proBNP; (N-terminal pro-brain natriuretic peptide) by Siemens Healthcare Diagnostics Inc. Tarrytown
Regulator Germany / BfArM
Country DEU
Brand ADVIA Centaur NT-proBNP and Atellica IM NT-proBNP; (N-terminal pro-brain natriuretic peptide)
Manufacturer Siemens Healthcare Diagnostics Inc. Tarrytown
Models 20-01.A-2.OUS, 20-01.A-1.OUS, 11200588, 10699450, 10591, 11200589, 10699449, N=122, N=124
Date Jan 20, 2020
Regulator page bfarm.de

At a glance

  • No Recall
  • No Field safety notice
  • 10–99 Matching device models in FDA data
  • 10–99 Matching catalog numbers in FDA data

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About International device safety notices

Field safety notices, recalls and safety alerts published by about 30 national medical device regulators outside the United States, matched by Orca1 to FDA device data.

Source: National medical device regulators (as listed), compiled by Orca1

Browse all International device safety notices